AliveCor QT Service vs Zio ECG Utilization Software (ZEUS) System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
AI Verdict
Tool A specializes in instant QT and QTc interval measurements from 6-Lead ECGs to assess cardiac safety and inform medication prescribing. In contrast, Tool B focuses on analyzing continuous ECG data from wearable monitors to aid in the diagnosis and management of cardiac arrhythmias. While both leverage AI for ECG analysis in cardiology, their distinct clinical applications make them adjacent rather than direct competitors.
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary need is immediate and accurate QT/QTc interval measurement to assess cardiac safety, especially when considering or monitoring medications known to affect the QT interval. This tool is ideal for healthcare professionals requiring rapid insights for critical prescribing decisions and risk stratification in a clinical setting.
View AliveCor QT Service →Choose Zio ECG Utilization Software (ZEUS) System if…
Choose Zio ECG Utilization Software (ZEUS) System if you require comprehensive, continuous ECG monitoring over an extended period (up to 14 days) to detect and classify intermittent cardiac arrhythmias. This system is best suited for diagnosing and managing patients with suspected or known arrhythmias that may not be captured during a brief, point-in-time ECG.
View Zio ECG Utilization Software (ZEUS) System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact for pricing |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Cloud-based (AWS EC2 platform) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Company | AliveCor | iRhythm Technologies |
| Primary Function/Measurement | Provides instant, accurate QT and QTc interval measurements. | Analyzes continuous ECG data to aid physicians in the diagnosis and management of cardiac arrhythmias. |
| ECG Data Source | AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L) | Wearable Zio monitors (Zio monitor, Zio Watch) |
| AI/Algorithm Use | Utilizes AI and deep neural networks for ECG analysis. | AI algorithm for arrhythmia detection and classification; proprietary deep-learned algorithms. |
| Integration Capabilities | API available for integration with EHR, SDK, CRM, EDC, and PSP platforms; Integrates with KardiaStation app and KardiaPro portal. | HL7-based EHR integration; ZioSuite web portal and mobile application. |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Zio ECG Utilization Software (ZEUS) System.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) designed to provide instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs. This enables healthcare professionals to assess cardiac safety and inform medication prescribing decisions. In contrast, the Zio ECG Utilization Software (ZEUS) System is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
AliveCor QT Service analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices, such as KardiaMobile 6L, providing instant QT measurements. The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data for up to 14 days from proprietary wearable Zio monitors, including the Zio monitor and Zio Watch.
AliveCor QT Service utilizes AI and deep neural networks to provide instant and accurate QT and QTc interval measurements (InstantQT). The Zio ECG Utilization Software (ZEUS) System employs AI algorithms and proprietary deep-learned algorithms for arrhythmia detection and classification, generating comprehensive end-of-wear reports for physician review.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. The Zio ECG Utilization Software (ZEUS) System integrates with the ZioSuite web portal and mobile application for healthcare professionals, and supports HL7-based EHR integration.
AliveCor QT Service is indicated for prescription (Rx) use only by qualified healthcare professionals for adult patients (older than 18 years) to assess cardiac safety and inform medication prescribing decisions. The Zio ECG Utilization Software (ZEUS) System is indicated for use on patients 18 years or older who may be asymptomatic or suffer from transient symptoms like palpitations or dizziness, aiding in arrhythmia diagnosis and management, but is not intended for critical care patients.
AliveCor QT Service provides instant QT measurements from previously acquired 6-Lead ECGs, focusing on immediate assessment of QT intervals. The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data collected over an extended period (up to 14 days) from wearable monitors, generating a preliminary end-of-wear report for retrospective review by physicians.
More Comparisons
More matchups featuring AliveCor QT Service or Zio ECG Utilization Software (ZEUS) System
Backers
Who funded each tool's parent company.